miRNA–mRNA Control of Juvenile Hormone Biosynthesis
2026-09-05
Li and colleagues identify coordinated miRNA–mRNA modules that release multiple juvenile hormone synthesis genes in the locust corpora allata during vitellogenesis. Their perturbation experiments connect this post-transcriptional control to vitellogenin expression and ovarian development, clarifying how high juvenile hormone output supports adult reproduction.
HOXC8, Caspase-1, and Pyroptosis in Lung Cancer
2026-09-05
A 2025 Cell Death and Disease study identifies HOXC8 as a transcriptional suppressor of caspase-1 expression in non-small cell lung carcinoma, linking a developmental transcription factor to pyroptotic cell death. The work suggests that disrupting HOXC8–HDAC1/2 control of the CASP1 promoter may expose a tumor-cell vulnerability that can be tested with genetic, pharmacological, and in vivo approaches.
Fingolimod (FTY720): Assay Reliability Guide
2026-09-04
A scenario-based guide to using Fingolimod (FTY720), SKU A8548, in cell viability, proliferation, and cytotoxicity workflows. It connects receptor pharmacology with practical stock preparation, dose selection, data interpretation, and product-quality decisions.
AZD8055 Protocol Guide for mTOR Inhibition
2026-09-04
AZD8055 is an ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling in cellular, biochemical, and selected animal models. It is useful for mechanistic cancer and metabolism research, but its poor aqueous solubility and limited clinical benefit make it unsuitable for studies requiring water-based formulation or clinical efficacy conclusions.
Oligo (dT) 25 Beads for mRNA Assay Design
2026-09-03
Discover how Oligo (dT) 25 Beads can convert polyA tail mRNA capture into a mechanistically informed workflow for cancer transcriptomics. This guide connects selective mRNA purification with assay decisions inspired by NSD1–PPARγ–PTEN biology.
Cyclosporin A in Synaptic and Immune Assays
2026-09-03
Cyclosporin A offers a versatile perturbation strategy for calcineurin–NFAT signaling, mitochondrial pore control, and mechanistic neurobiology. This guide connects practical assay design with findings from a cortical interneuron study while emphasizing controls, dose selection, and troubleshooting.
DAPT (GSI-IX) for Corneal Cell Assays
2026-09-02
DAPT (GSI-IX) provides a practical chemical switch for testing how γ-secretase-dependent Notch and APP processing influence cell fate, proliferation, and differentiation. Its value is especially clear when paired with the six-component corneal epithelial culture strategy described in the reference study, where pathway modulation is separated from lineage and barrier readouts.
HPF for hROS: Assay Design Beyond ROS Imaging
2026-09-02
HPF (hydroxyphenyl fluorescein) enables selective highly reactive oxygen species detection with low basal fluorescence. This guide explains how to use its chemistry to distinguish hROS biology from broad oxidative stress signals, including in phototherapy-focused assays.
Biodentine Rejuvenates Aging Dental Pulp Stem Cells
2026-09-01
The reference study identifies Biodentine as more than a passive pulp-capping material: it promoted proliferation and reduced senescence-associated changes in human dental pulp stem cells through Wnt/β-catenin signaling. These findings strengthen the biological rationale for age-aware vital pulp therapy while highlighting the need for further validation in complex tissue and clinical models.
Clozapine N-oxide and Circadian Circuit Control
2026-08-31
A translational framework for using Clozapine N-oxide (CNO) and DREADDs to test how SCN circuit activity connects time-restricted feeding with the IGF2-KCC2 pathway, while preserving pharmacological rigor and experimental controls.
S-Adenosylhomocysteine in Neural Assay Design
2026-08-31
S-Adenosylhomocysteine (SAH) provides a controlled way to study methyltransferase inhibition and SAM/SAH ratio modulation alongside radiation-induced neural differentiation. This article translates biochemical principles into a hypothesis-driven assay framework while clearly separating established evidence from experimental opportunity.
gamma-Glu-Cys (γ-Glu-Cys) Lab Guide
2026-08-30
This practical guide explains how to use gamma-Glu-Cys (γ-Glu-Cys) as a substrate and intermediate in glutathione-related workflows, with emphasis on fresh solution preparation, solvent selection, and assay controls. It is intended for scientific research such as glutathione synthetase enzyme assays and plant studies, not for diagnostic, clinical, or therapeutic use.
Tacrine Hydrochloride Hydrate in AD Assays
2026-08-29
Tacrine hydrochloride hydrate provides a practical benchmark for connecting cholinesterase inhibition with neuronal and neuroprotection readouts. This guide translates its reported potency, formulation considerations, and known hepatotoxicity liability into reproducible Alzheimer’s disease research workflows.
Ciprofloxacin for Reliable Cell and Infection Assays
2026-08-29
This scenario-driven guide explains how Ciprofloxacin SKU A8399 can support reproducible bacterial infection, antimicrobial resistance, and viability workflows while highlighting solubility, storage, and interpretation limits. It connects product specifications with recent nanotheranostic evidence and practical laboratory controls.
EZ Cap™ Cre mRNA (m1Ψ): Assay Design
2026-08-28
Learn how EZ Cap™ Cre mRNA (m1Ψ) supports transient Cre recombinase mRNA expression and how to separate RNA delivery, translation, and loxP recombination during assay design. This guide connects mRNA chemistry with practical controls for gene editing and gene therapy research.
458 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page